Search Results 11711-11720 of 35009 for oral
A study cycle will consist of daily and continuous oral administration of BBI608 for four weeks (28 days) in combination with FOLFOX6 with and without ...
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma Jacksonville, FL; Rochester, MN. The purpose of this study ...
l cancer, Oral and throat cancer, Salivary gland cancer, Thyroid cancer, Head and neck cancer, Skin cancer, Chondrosarcoma, Nasopharyngeal carcinoma ...
ROCHESTER, Minn.— A new year offers new beginnings and an opportunity to reset your eating habits after the holidays. Andrea Delgado, a Mayo Clinic ...
Research · Science Saturday: What you should know about genetics, colorectal cancer featured image · Research · Mayo researchers use AI to detect weak heart pump ...
Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...
Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients. Joe Dangor. November 11, 2015. Cardiovascular. Genetic Risk Information ...
Florida. Mayo Clinic awarded $5.3 million federal grant to study vascular risk factors in dementia. Kevin Punsky. November 12, 2015. Cancer. Prior Oral ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.